ANI Pharmaceuticals Inc (ANIP)
65.41
-0.68
(-1.03%)
USD |
NASDAQ |
Apr 24, 16:00
65.41
0.00 (0.00%)
After-Hours: 17:57
ANI Pharmaceuticals Cash from Investing (TTM): -18.51M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -18.51M |
| September 30, 2023 | -16.87M |
| June 30, 2023 | -22.14M |
| March 31, 2023 | -15.91M |
| December 31, 2022 | -15.74M |
| September 30, 2022 | -94.81M |
| June 30, 2022 | -85.58M |
| March 31, 2022 | -106.92M |
| December 31, 2021 | -105.48M |
| September 30, 2021 | -25.39M |
| June 30, 2021 | -30.62M |
| March 31, 2021 | -11.51M |
| December 31, 2020 | -68.32M |
| September 30, 2020 | -67.58M |
| June 30, 2020 | -63.70M |
| March 31, 2020 | -64.81M |
| December 31, 2019 | -27.55M |
| September 30, 2019 | -26.58M |
| June 30, 2019 | -43.09M |
| March 31, 2019 | -45.39M |
| December 31, 2018 | -27.38M |
| September 30, 2018 | -77.09M |
| June 30, 2018 | -61.13M |
| March 31, 2018 | -57.18M |
| December 31, 2017 | -107.99M |
| Date | Value |
|---|---|
| September 30, 2017 | -59.27M |
| June 30, 2017 | -57.88M |
| March 31, 2017 | -116.60M |
| December 31, 2016 | -149.06M |
| September 30, 2016 | -148.78M |
| June 30, 2016 | -174.46M |
| March 31, 2016 | -113.62M |
| December 31, 2015 | -32.68M |
| September 30, 2015 | -31.92M |
| June 30, 2015 | -27.68M |
| March 31, 2015 | -27.73M |
| December 31, 2014 | -35.75M |
| September 30, 2014 | -33.18M |
| June 30, 2014 | -10.69M |
| March 31, 2014 | 8.892M |
| December 31, 2013 | 20.27M |
| September 30, 2013 | 17.95M |
| June 30, 2013 | 17.52M |
| March 31, 2013 | -1.817M |
| December 31, 2012 | -0.6191M |
| September 30, 2012 | -0.611M |
| June 30, 2012 | -0.2483M |
| March 31, 2012 | -0.5609M |
| December 31, 2011 | -0.7199M |
| September 30, 2011 | -0.6793M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-106.92M
Minimum
Mar 2022
-11.51M
Maximum
Mar 2021
-47.95M
Average
-30.62M
Median
Jun 2021
Cash from Investing (TTM) Benchmarks
| Ligand Pharmaceuticals Inc | -11.68M |
| ADMA Biologics Inc | -4.981M |
| Dentsply Sirona Inc | -89.00M |
| Allogene Therapeutics Inc | 163.29M |
| Vanda Pharmaceuticals Inc | -12.06M |